Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SPMO vs GSK✓SelectedUSD · GSKSPMO vs GSK performance historyLatest closeAs of-2.09%11/19
Stock and ETF performance explorer

SPMO vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+7.2%
GSK return
+5.3%
Excess return
+1.8%
Maximum drawdown
-24.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.1%-1.6%-0.5%-2.2%
7D-7.7%-4.7%-3.0%-8.1%
30D-12.6%-4.7%-7.9%-12.9%
3M-16.3%-8.8%-7.5%-16.5%
6M-11.5%-4.6%-6.9%-11.7%
YTD+4.6%+1.0%+3.6%+4.0%
1Y+7.2%+6.9%+0.3%+5.7%
All+7.2%+5.3%+1.8%+5.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling